Pancrelipase Market: Global Industry Analysis and Forecast (2021-2027) Trends, Statistics, Dynamics and Segmentation

Pancrelipase Market was valued at US$ 1056.7 Mn. in 2021. Global Pancrelipase Market size is expected to grow at a CAGR of 4.3 % through the forecast period.

Pancrelipase Market Overview:

Pancrelipase is a mixture of pancreatic enzymes like- amylase, lipase, and protease which are derived from the porcine pancreatic gland that is used as a supplement to aid the digestion of fats, lipids, sugar, and starch. It is the best alternative for people suffering from digestion-related problems in which their pancreases are not able to produce a sufficient number of pancreatic enzymes. In that case, Pancrelipase works as a supplement to help them fight their weakness. Many industrialists are looking to add Pancrelipase to their production list as it is needed in the current scenario. Nowadays, even children are facing digestion problems owing to the shift to a modern lifestyle and increasing urbanization. The drug is in its growing phase and the industrialists are spending their big chunks to get more health-benefits from the drug. Pancrelipase Market To know about the Research Methodology :- Request Free Sample Report 2021 is considered as a base year to forecast the market from 2022 to 2027. 2020’s market size is estimated on real numbers and outputs of the key players and major players across the globe. Past five years' trends are considered while forecasting the market through 2027. 2020 is a year of exception and analysis especially with the impact of lockdown by region.

Pancrelipase Market Dynamics:

Market Drivers: First-line therapy for exocrine pancreatic insufficiency: Pancrelipase is first-line therapy for Exocrine pancreatic insufficiency. It is a condition in which the pancreas decreases its capacity to produce pancreatic juice, which includes amylase, lipase, and protease and helps in the breakdown of lipids, proteins, sugar, and starch in the intestinal tract. This pancreatic juice is necessary for proper digestion of the food, if the concentration of this pancreatic juice falls below the normal level, then it may cause digestion problems. Exocrine pancreatic insufficiency is caused by a variety of disorders, including chronic pancreatitis, cystic fibrosis, pancreatic cancer, post-pancreatectomy, and post-gastrointestinal bypass surgery. These increasing conditions of indigestion are driving the growth of the Pancrelipase Market. Increased prevalence of pancreatitis: Pancreatitis is an inflammation of the pancreas. In this disease, its ability to produce pancreatic juices get decreased. In this condition, doctors prefer to prescribe Pancrelipase to the patients. Increased prevalence of pancreatitis is driving the market. Pancrelipase provides a targeted approach, it starts to work in the small intestine in the same manner as pancreatic juice does. It is also administered to people who have had replacement therapy. It is also administered to people who have had replacement therapy. Changing lifestyle of people and unhealthy diet: Nowadays, the lifestyle of people is changing rapidly, they are shifting towards a new and unhealthy lifestyle which includes an unhealthy diet. Increasing unhealthy diet is resulting in an increase in cases of indigestion and stomach disorders. This is driving the Pancrelipase Market growth. According to the MMR, around 60-70 million individuals in the United States suffer from digestive disorders. This indicates that Pancrelipase Market is in high demand in this region. Also, individuals all over the world are suffering from digestive issues, and doctors are suggesting they include Pancrelipase in their diets. As a result, the growth of the Pancrelipase Market is increasing. Market Restraints: Lack of awareness about Pancrelipase: There is a lack of awareness about Pancrelipase among many healthcare professionals also. This is restraining the growth of the Pancrelipase Market. Market Opportunities: Increased awareness about healthy life: The absorption and digestion of food are essential for a healthy life of people. Increasing awareness in people about the health concerns and the importance of healthy life is resulting in increased demand for the Pancrelipase for improving digestion. This indirectly leads to an improved and healthy life. This is an opportunity for the players in this Pancrelipase Market for their growth.

Pancrelipase Market COVID-19 Insights:

COVID-19 pandemic resulted in country lockdown and shutdown of businesses also. This affected a large number of aspects of the Pancrelipase market, including an unexpected halt in the production process, finance, and manufacturing operations in many business sectors. This decreased the growth of the Pancrelipase Market. But the demand for Pancrelipase increased because of its health benefits.

Pancrelipase Market Segment Analysis:

Based on Type, with 57% share in 2021, the Capsules segment dominated the Pancrelipase market. Capsules are more easily broken down than tablets. They may provide faster symptom recovery than tablets. They are frequently designed in such a way that splitting or crushing them is difficult. Because capsules have a higher bioavailability, more of the drug will enter your circulation. As a result, capsules may be somewhat more effective than tablets. Hence, capsules are preferred more as compared to tablets. This is driving the growth of the capsule segment of the Pancrelipase market. Pancrelipase Market Based on the Application, the Pharmaceutical Sector segment dominated the Pancrelipase Market with 42% share in 2021. Because of the increase in cases of indigestion problems, there is a rise in the use of Pancrelipase in the pharmaceutical sector for various applications. As the Pancrelipase is used as an alternative for the pancreatic enzymes, this use in the production of pharmaceutical products is also increased. This results in the growth of this Pharmaceutical Sector segment of the Pancrelipase Market. Based on the Age of the End User, in 2021, the adults segment dominated the market with 39% share. This is due to the changing habits and unhealthy diet of the people. As compared to children and the geriatrics population, these habits are more in adults. These factors lead to a rise in the health-related issues of adults and increased growth of this segment of the Pancrelipase Market. Pancrelipase Market Based on Distribution Channel, in 2021, the Pancrelipase Market is dominated by the B2C segment with 59% share. The B2C segment includes medical stores, specialty stores, and online retailers also. Nowadays, people prefer online platforms for purchasing medicines because of various services, additional discounts, and offers. As a result, there is more growth in the online retailer segment which is a B2C segment.

Pancrelipase Market Regional Insights:

The Europe region dominated the market with 43 % share in 2021. Increased prevalence of pancreatitis in this region results in a decrease in the pancreatic juice-producing ability of the pancreas. This leads to increased demand for Pancrelipase, which directly drives the growth of the Pancrelipase Market in this region. Also, urbanization and changing lifestyles of the people are driving the market in this region. The Asia-Pacific region is expected to witness significant growth at a CAGR of 4.1% through the forecast period. Increasing population and indigestion problems because of the unhealthy diet of people in this region is increasing the demand for Pancrelipase. This will drive the market in this region during the forecast period. Pancrelipase Market The objective of the report is to present a comprehensive analysis of the global Pancrelipase Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The reports also help in understanding the Pancrelipase Market dynamic, structure by analyzing the market segments and projecting the Pancrelipase Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Pancrelipase Market make the report investor’s guide.

Pancrelipase Market Scope: Inquire before buying

Global Pancrelipase Market
Report Coverage Details
Base Year: 2021 Forecast Period: 2022-2027
Historical Data: 2017 to 2021 Market Size in 2021: US $ 1056.7 Mn.
Forecast Period 2022 to 2027 CAGR: 4.3% Market Size in 2027: US $ 1360.4 Mn.
Segments Covered: by Type • Capsules • Tablets
by Application • Pharmaceutical Sector • Chemical Sector • Food Sector
by Age of End User • Children • Adults • Geriatrics
by Distribution Channel • B2B • B2C

Pancrelipase Market by Region

• North America • Europe • Asia Pacific • South America • Middle East and Africa

Pancrelipase Market Key Players

• Allergan Pharmaceuticals International Limited. • VIVUS, Inc.Abbot • Forest Laboratories • PDR, LLC. • Amano Enzyme Inc. • Beijing Geyuantianrun Biotech Co, Ltd. • Kin Master Products Quimicos Ltd • Laboratories opoterapicon Argentino SA • Meenany Pharma Pvt. Ltd • Scientific Protein Laboratories LLC • Sichuan Deebio Pharmaceutical Co., Ltd. Frequently Asked Questions: 1] What segments are covered in the Global Pancrelipase Market report? Ans. The segments covered in the Pancrelipase Market report are based on Type, Application, Age of End User and Distribution Channel. 2] Which region is expected to hold the highest share in the Global Pancrelipase Market? Ans. The Europe is expected to hold the highest share in the Pancrelipase Market. 3] What is the market size of the Global Pancrelipase Market by 2027? Ans. The market size of the Pancrelipase Market by 2027 is expected to reach US$ 1360.4 Mn. 4] What is the forecast period for the Global Pancrelipase Market? Ans. The forecast period for the Pancrelipase Market is 2021-2027. 5] What was the market size of the Global Pancrelipase Market in 2021? Ans. The market size of the Pancrelipase Market in 2021 was valued at US$ 1056.7 Mn.
1. Global Pancrelipase Market Size: Research Methodology 2. Global Pancrelipase Market Size: Executive Summary 2.1. Market Overview and Definitions 2.1.1. Introduction to Global Pancrelipase Market Size 2.2. Summary 2.2.1. Key Findings 2.2.2. Recommendations for Investors 2.2.3. Recommendations for Market Leaders 2.2.4. Recommendations for New Market Entry 3. Global Pancrelipase Market Size: Competitive Analysis 3.1. MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2. Consolidation in the Market 3.2.1 M&A by region 3.3. Key Developments by Companies 3.4. Market Drivers 3.5. Market Restraints 3.6. Market Opportunities 3.7. Market Challenges 3.8. Market Dynamics 3.9. PORTERS Five Forces Analysis 3.10. PESTLE 3.11. Regulatory Landscape by region • North America • Europe • Asia Pacific • Middle East and Africa • South America 3.12. COVID-19 Impact 4. Global Pancrelipase Market Size Segmentation 4.1. Global Pancrelipase Market Size, by Type (2021-2027) • Capsules • Tablets 4.2. Global Pancrelipase Market Size, by Application (2021-2027) • Pharmaceutical Sector • Chemical Sector • Food Sector 4.3. Global Pancrelipase Market Size, by Age of End User (2021-2027) • Children • Adults • Geriatrics 4.4. Global Pancrelipase Market Size, by Distribution Channel (2021-2027) • B2B • B2C 5. North America Pancrelipase Market (2021-2027) 5.1. North America Pancrelipase Market Size, by Type (2021-2027) • Capsules • Tablets 5.2. North America Pancrelipase Market Size, by Application (2021-2027) • Pharmaceutical Sector • Chemical Sector • Food Sector 5.3. North America Pancrelipase Market Size, by Age of End User (2021-2027) • Children • Adults • Geriatrics 5.4. North America Pancrelipase Market Size, by Distribution Channel (2021-2027) • B2B • B2C 5.5. North America Pancrelipase Market, by Country (2021-2027) • United States • Canada • Mexico 6. European Pancrelipase Market (2021-2027) 6.1. European Pancrelipase Market, by Type (2021-2027) 6.2. European Pancrelipase Market, by Application (2021-2027) 6.3. European Pancrelipase Market, by Age of End User (2021-2027) 6.4. European Pancrelipase Market, by Distribution Channel (2021-2027) 6.5. European Pancrelipase Market, by Country (2021-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 7. Asia Pacific Pancrelipase Market (2021-2027) 7.1. Asia Pacific Pancrelipase Market, by Type (2021-2027) 7.2. Asia Pacific Pancrelipase Market, by Application (2021-2027) 7.3. Asia Pacific Pancrelipase Market, by Age of End User (2021-2027) 7.4. Asia Pacific Pancrelipase Market, by Distribution Channel (2021-2027) 7.5. Asia Pacific Pancrelipase Market, by Country (2021-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 8. Middle East and Africa Pancrelipase Market (2021-2027) 8.1. Middle East and Africa Pancrelipase Market, by Type (2021-2027) 8.2. Middle East and Africa Pancrelipase Market, by Application (2021-2027) 8.3. Middle East and Africa Pancrelipase Market, by Age of End User (2021-2027) 8.4. Middle East and Africa Pancrelipase Market, by Distribution Channel (2021-2027) 8.5. Middle East and Africa Pancrelipase Market, by Country (2021-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 9. South America Pancrelipase Market (2021-2027) 9.1. South America Pancrelipase Market, by Type (2021-2027) 9.2. South America Pancrelipase Market, by Application (2021-2027) 9.3. South America Pancrelipase Market, by Age of End User (2021-2027) 9.4. South America Pancrelipase Market, by Distribution Channel (2021-2027) 9.5. South America Pancrelipase Market, by Country (2021-2027) • Brazil • Argentina • Rest Of South America 10. Company Profile: Key players 10.1. Allergan Pharmaceuticals International Limited 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. VIVUS Inc 10.3. Abbot 10.4. Forest Laboratories 10.5. PDR Inc 10.6. Amano Enzymes Inc 10.7. Beijing Geyuantianrun Biotech CO, Ltd 10.8. Kin Master Products Quimicos Ltd 10.9. Laboratories Opoterapicon Argentino SA 10.10. Meenany Pharma Pvt Ltd 10.11. Scientific Protein Laboratories LLC 10.12. Sichuan Deebio Pharmaceuticals Co, Ltd

About This Report

Report ID 148596
Category Food & Beverages
Published Date May 2022
Updated Date
Contact Us